ACTIVE

Fevery-Dewitte

Export PDF

Financial year 2024 · closed on 31/12/2024

Net result

115 k €

+17.3% YoY

Gross margin

316 k €

+12.6% YoY

Equity

425,6 k €

+1.8% YoY

Workforce

1,9 ETP

-38.7% YoY

What does Fevery-Dewitte do?

Fevery-Dewitte is a Private limited company incorporated in 2005. Its registered office is in Brugge. It employs on average 1,9 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0878.046.473

Incorporation

20/12/2005

Legal form

Private limited company

Registered office

Zuidzandstraat 1
8000 Brugge · FlandreSee on map

Contributed capital

25 000,00 €

Latest accounts

31/12/2024

Average workforce

1,9 ETP

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 19 financial years

	2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Gross margin	316 k €	+12.6%	280,8 k €	+18.5%	237 k €	+28.4%	184,5 k €	+36.0%	135,7 k €	-9.5%	149,9 k €	-7.2%	161,6 k €	+2.6%	157,4 k €	-15.0%	185,1 k €	-12.8%	212,4 k €	+5.2%	201,8 k €	-15.7%	239,2 k €	+35.7%	176,3 k €	+40.5%	125,5 k €	+2.6%	122,3 k €	-9.7%	135,4 k €	-11.9%	153,8 k €	-4.0%	160,2 k €	-9.8%	177,6 k €
EBITDA	150,4 k €	+10.8%	135,8 k €	-6.3%	144,9 k €	+41.8%	102,2 k €	+85.2%	55,2 k €	-33.8%	83,4 k €	-7.3%	90 k €	-9.5%	99,4 k €	-24.1%	131 k €	-15.6%	155,2 k €	+1.2%	153,3 k €	-18.7%	188,7 k €	+27.2%	148,3 k €	+30.7%	113,5 k €	+5.5%	107,6 k €	-6.0%	114,5 k €	-6.3%	122,1 k €	-12.4%	139,4 k €	+21.7%	114,5 k €
Operating result	138 k €	+12.9%	122,3 k €	-8.2%	133,1 k €	+57.2%	84,7 k €	+147%	34,2 k €	-13.7%	39,7 k €	-13.0%	45,6 k €	-18.6%	56 k €	-39.8%	93 k €	+10.5%	84,2 k €	+15.5%	72,9 k €	-28.3%	101,8 k €	+85.1%	55 k €	-21.7%	70,2 k €	+42.2%	49,4 k €	-6.0%	52,5 k €	-14.3%	61,3 k €	-21.9%	78,5 k €	+31.2%	59,9 k €
Net result	115 k €	+17.3%	98 k €	-8.7%	107,4 k €	+53.3%	70 k €	+226%	21,5 k €	-9.4%	23,7 k €	-20.7%	29,9 k €	-26.9%	40,9 k €	-41.9%	70,4 k €	+17.1%	60,1 k €	+37.8%	43,6 k €	-35.7%	67,8 k €	+93.2%	35,1 k €	-18.8%	43,2 k €	+119%	19,8 k €	-31.9%	29 k €	-8.4%	31,7 k €	-38.6%	51,6 k €	+19.3%	43,3 k €
Balance sheet
Equity	425,6 k €	+1.8%	418,1 k €	+13.0%	370,1 k €	+15.6%	320,2 k €	-41.8%	550,2 k €	+4.1%	528,8 k €	+4.7%	505,1 k €	+4.8%	481,7 k €	+4.5%	460,9 k €	+9.6%	420,5 k €	+10.5%	380,4 k €	+12.9%	336,8 k €	+25.2%	269 k €	+13.4%	237,1 k €	+20.3%	197,2 k €	+9.2%	180,6 k €	+19.1%	151,6 k €	+26.4%	119,9 k €	+75.6%	68,3 k €
Total assets	709,6 k €	+21.8%	582,5 k €	-26.7%	794,9 k €	+7.6%	738,7 k €	+12.8%	655 k €	+1.2%	647,2 k €	+9.1%	593,4 k €	-0.8%	598,5 k €	+1.8%	587,9 k €	+1.7%	578,2 k €	+2.6%	563,7 k €	-1.3%	571,1 k €	-2.5%	585,6 k €	+4.7%	559,1 k €	-3.5%	579,4 k €	-8.3%	631,8 k €	-6.0%	672,1 k €	+3.6%	649 k €	+0.6%	645,3 k €
Cash	393,7 k €	+67.4%	235,3 k €	-57.4%	551,6 k €	+20.9%	456,4 k €	+27.0%	359,4 k €	+11.4%	322,5 k €	+42.1%	226,9 k €	+7.2%	211,6 k €	-3.7%	219,8 k €	-1.1%	222,3 k €	+25.8%	176,8 k €	+29.8%	136,2 k €	+85.0%	73,6 k €	-24.9%	98,1 k €	+94.1%	50,5 k €	-25.7%	68 k €	-67.5%	209 k €	+44.8%	144,3 k €	+53.4%	94,1 k €
Debts	279,4 k €	+70.0%	164,4 k €	-61.3%	424,8 k €	+1.6%	418,2 k €	+299%	104,8 k €	-11.5%	118,4 k €	+39.0%	85,2 k €	-23.1%	110,7 k €	-10.8%	124,1 k €	-19.8%	154,7 k €	-1.3%	156,7 k €	-24.5%	207,5 k €	-27.8%	287,1 k €	-1.2%	290,6 k €	-17.7%	353,1 k €	-16.3%	422 k €	-15.7%	500,4 k €	-5.0%	526,9 k €	-8.3%	574,3 k €
Other
Workforce	1,9 ETP	-38.7%	3,1 ETP	+82.4%	1,7 ETP	+54.5%	1,1 ETP	-26.7%	1,5 ETP	+15.4%	1,3 ETP	-7.1%	1,4 ETP	-12.5%	1,6 ETP	+60.0%	1,0 ETP	0.0%	1,0 ETP	0.0%	1,0 ETP	+11.1%	0,9 ETP	+80.0%	0,5 ETP	+150%	0,2 ETP	-50.0%	0,4 ETP	0.0%	0,4 ETP	0.0%	0,4 ETP	-20.0%	0,5 ETP	-58.3%	1,2 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2024 · 2 active · 6 ended

Active mandates

FEVERY PHARMA

Director · since 31 mai 2014 · 0552.675.811

Represented by Wouter Fevery

Active

Rony Fevery

Director · since 01 janvier 2006

Active

Ended mandates

FEVERY PHARMA

Director · since 31 mai 2014 · 0552.675.811

Represented by Wouter Fevery

Ended

FEVERY PHARMA

Manager · since 31 mai 2014 · 0552.675.811

Represented by Wouter Fevery

Ended

WOUTER FEVERY

Manager · since 02 janvier 2011 · until 31 mai 2014

Ended

WOUTER FEVERY

Manager · since 02 janvier 2011

Ended

At this address

Other companies at this address

Company	CBE no.
FEVERY PHARMA● Active	0552.675.811
FEVERY VASTGOED● Active	0746.884.657

Annual accounts

Full financial information

	2024	2023	2022	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	03/07/2025	17/06/2024	25/07/2023	28/06/2022	22/06/2021	17/08/2020
General meeting	27/06/2025	24/05/2024	30/06/2023	27/05/2022	28/05/2021	30/06/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

19 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2024	27/06/2025	03/07/2025	Dutch	PDF
Abridged model	31/12/2023	24/05/2024	17/06/2024	Dutch	PDF
Abridged model	31/12/2022	30/06/2023	25/07/2023	Dutch	PDF
Abridged model	31/12/2021	27/05/2022	28/06/2022	Dutch	PDF
Abridged model	31/12/2020	28/05/2021	22/06/2021	Dutch	PDF
Abridged model	31/12/2019	30/06/2020	17/08/2020	Dutch	PDF
Abridged model	31/12/2018	30/06/2019	06/08/2019	Dutch	PDF
Abridged model	31/12/2017	30/06/2018	31/07/2018	Dutch	PDF
Abridged model	31/12/2016	30/06/2017	28/07/2017	Dutch	PDF
Abridged model	31/12/2015	20/06/2016	18/07/2016	Dutch	PDF
Abridged model	31/12/2014	26/06/2015	12/08/2015	Dutch	PDF
Abridged model	31/12/2013	28/06/2014	28/08/2014	Dutch	PDF
Abridged model	31/12/2012	29/06/2013	16/08/2013	Dutch	PDF
Abridged model	31/12/2011	30/06/2012	24/08/2012	Dutch	PDF
Abridged model	31/12/2010	24/05/2011	23/08/2011	Dutch	PDF
Abridged model	31/12/2009	28/05/2010	30/08/2010	Dutch	PDF
Abridged model	31/12/2008	22/05/2009	28/08/2009	Dutch	PDF
Abridged model	31/12/2007	23/05/2008	29/08/2008	Dutch	PDF
Abridged model	31/12/2006	27/05/2007	28/08/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2024 · 2 active · 6 ended

Active mandates

FEVERY PHARMA

Director · since 31 mai 2014 · 0552.675.811

Represented by Wouter Fevery

Active

Rony Fevery

Director · since 01 janvier 2006

Active

Ended mandates

FEVERY PHARMA

Director · since 31 mai 2014 · 0552.675.811

Represented by Wouter Fevery

Ended

FEVERY PHARMA

Manager · since 31 mai 2014 · 0552.675.811

Represented by Wouter Fevery

Ended

WOUTER FEVERY

Manager · since 02 janvier 2011 · until 31 mai 2014

Ended

WOUTER FEVERY

Manager · since 02 janvier 2011

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates05/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DOEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
PDF
Mandates30/12/2019
ONTSLAGEN - BENOEMINGEN
PDF
Mandates23/06/2014
ONTSLAGEN - BENOEMINGEN
PDF
Mandates09/10/2012
ONTSLAGEN - BENOEMINGEN
PDF
Other30/12/2005
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2024
Annual accounts 2024115 k €↑
2023
Annual accounts 202398 k €↓
2022
Annual accounts 2022107,4 k €↑
2021
Annual accounts 202170 k €↑
2020
Annual accounts 202021,5 k €↓
2019
Annual accounts 201923,7 k €↓
2018
Annual accounts 201829,9 k €↓
2017
Annual accounts 201740,9 k €↓
2016
Annual accounts 201670,4 k €↑
2015
Annual accounts 201560,1 k €↑
2014
Annual accounts 201443,6 k €↓
2013
Annual accounts 201367,8 k €↑
2012
Annual accounts 201235,1 k €↓
2011
Annual accounts 201143,2 k €↑
2010
Annual accounts 201019,8 k €↓
2009
Annual accounts 200929 k €↓
2008
Annual accounts 200831,7 k €↓
2007
Annual accounts 200751,6 k €↑
2006
Annual accounts 200643,3 k €
20/12/2005
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

Fevery-Dewitte

Overview

What does Fevery-Dewitte do?

Trend over 19 financial years

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline